We aimed to evaluate if reducing the time between biopsy and scan led to a decrease in staging accuracy due to post biopsy haemorrhage.
RESULTS: Comparison of pre-CMT ERUS stage with pathologic stage revealed a decrease in T stage in 93 patients (49%), as well as a decrease in the percentage of individuals with positive MLNs, from 54% to 27% (P <.0001).
Also, the pathological end point used in both studies was a decrease in T stage determined by comparison of pretreatment transrectal ultrasound (TRUS) and postoperative pathological staging, which may be unreliable.
Renal recovery was defined by a decrease in one stage or more according to the KDIGO classification.
As mentioned above, some miRNAs exhibited a decrease in each stage after mutation of prg-1.
In addition, specific analyses of tumours that have undergone a decrease in T stage post-RCT showed that up to 41% of these may harbour residual tumour deposits in the lymph nodes (Medich et al, 2001; Zmora et al, 2004).
Complete recovery was defined as the absence of AKI, partial recovery as persistent AKI with a decrease in AKI stage compared with AKImax and no recovery as persistence of AKImax or worsening of AKI after ICU discharge.
Other studies focusing on colon and rectal cancers and prostate cancer also observed a decrease in unknown staging [ 2, 4].
Although not statistically significant, women overall, and particularly those aged 50 69 years, showed a downward stage shift, with an increase in stage I and a slight decrease in stage II cases compatible with what we expected from the literature (Coburn et al, 2004; Louwman et al, 2008).
